Morning Movers 06/06: (ADES) (RXII) (ENOC) (COOL) Higher; (SNSS) (OREX) (YMI) (BVN) Lower
Tweet
Share
E-mail
Get Alerts ADES Hot Sheet
Join SI Premium – FREE
ADA-ES, Inc. (NASDAQ: ADES) 48.6% HIGHER; today announced the sale of a 15.8% equity interest in Clean Coal Solutions, LLC, ADA-ES’s 50:50 joint venture with an affiliate of NexGen Resources Corporation, by ADA-ES and NexGen for $60 million to GSFS Investments I Corp., an affiliate of The Goldman Sachs Group, Inc. (NYSE: GS). Closing of the transaction was simultaneous with signing.
RXi Pharmaceuticals Corp (Nasdaq: RXII) 13.9% HIGHER; updates on NeuVax Phase 2. The NeuVax Phase 2 trials enrolled 182 patients, including node positive and node negative, HER2 1+, 2+ and 3+ patients. All patients received standard of care (SoC) therapy and were confirmed to be disease-free prior to enrollment. Click here to see the full report. The stock was also resumed at Buy by Roth Capital.
EnerNOC, Inc. (NASDAQ: ENOC) 13.8% HIGHER; today announced its strong support for the Order issued by the Federal Energy Regulatory Commission on June 3, 2011 regarding the methodology for valuing demand response resources in PJM's capacity market.
Majesco Entertainment Co. (Nasdaq: COOL) 12.4% HIGHER; is seeing upside related to a Navellier newsletter recommendation.
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) 11.3% LOWER; presents the adaptive study design for its Phase 3 VALOR trial of vosaroxin in acute myeloid leukemia. Click here to see the full report.
Orexigen Therapeutics (Nasdaq: OREX) 11.3% LOWER; continuing lower following bad news on the company's Contrave(R) NDA on Friday. The stock plummeted 33 percent on Friday. Shares have pushed below the $2 level for the first time.
YM BioSciences (AMEX: YMI) 11% LOWER; giving back all of the gains from Friday's late-day surge following interim Phase I/II data for its JAK1/JAK2 inhibitor CYT387.
Compania de Minas Buenaventura SA (NYSE: BVN) 10.5% LOWER; falling after opposition candidate Ollant Humala won Peru's presidential election. The new president advocates greater state control of Peru's natural resources.
SunOpta Inc. (Nasdaq: STKL) 10.1% HIGHER; shares are jumping in early trading Monday following being highlighted by Jim Cramer on Mad Money Friday. Click here to see our full write up.
Credicorp (NYSE: BAP) 9.7% LOWER; see Buenaventura. Stock was also downgraded from Outperform to Underperform at Raymond James.
Southern Copper (Nasdaq: SCCO) 9.3% LOWER; Peru stocks are falling today amid yesterday's presidential election.
BPZ Resources (NYSE: BPZ) 8.8% LOWER; related to the election of Ollanta Humala.
Progress Software Corporation (NASDAQ: PRGS) 8.5% LOWER; reports preliminary results for Q2. Sees non-GAAP Q2 revs of $134 million and EPS of 37 to 38 cents. Consensus sees revs of $137.19 million and EPS of 42 cents.
FiberTower (Nasdaq: FTWR) 8.1% LOWER; continuing lower following a recent run-up. Shares fell more than 33 percent last week following a 98 percent surge over Thursday, May 26, the 27th and May 31st.
To get this movers report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
RXi Pharmaceuticals Corp (Nasdaq: RXII) 13.9% HIGHER; updates on NeuVax Phase 2. The NeuVax Phase 2 trials enrolled 182 patients, including node positive and node negative, HER2 1+, 2+ and 3+ patients. All patients received standard of care (SoC) therapy and were confirmed to be disease-free prior to enrollment. Click here to see the full report. The stock was also resumed at Buy by Roth Capital.
EnerNOC, Inc. (NASDAQ: ENOC) 13.8% HIGHER; today announced its strong support for the Order issued by the Federal Energy Regulatory Commission on June 3, 2011 regarding the methodology for valuing demand response resources in PJM's capacity market.
Majesco Entertainment Co. (Nasdaq: COOL) 12.4% HIGHER; is seeing upside related to a Navellier newsletter recommendation.
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) 11.3% LOWER; presents the adaptive study design for its Phase 3 VALOR trial of vosaroxin in acute myeloid leukemia. Click here to see the full report.
Orexigen Therapeutics (Nasdaq: OREX) 11.3% LOWER; continuing lower following bad news on the company's Contrave(R) NDA on Friday. The stock plummeted 33 percent on Friday. Shares have pushed below the $2 level for the first time.
YM BioSciences (AMEX: YMI) 11% LOWER; giving back all of the gains from Friday's late-day surge following interim Phase I/II data for its JAK1/JAK2 inhibitor CYT387.
Compania de Minas Buenaventura SA (NYSE: BVN) 10.5% LOWER; falling after opposition candidate Ollant Humala won Peru's presidential election. The new president advocates greater state control of Peru's natural resources.
SunOpta Inc. (Nasdaq: STKL) 10.1% HIGHER; shares are jumping in early trading Monday following being highlighted by Jim Cramer on Mad Money Friday. Click here to see our full write up.
Credicorp (NYSE: BAP) 9.7% LOWER; see Buenaventura. Stock was also downgraded from Outperform to Underperform at Raymond James.
Southern Copper (Nasdaq: SCCO) 9.3% LOWER; Peru stocks are falling today amid yesterday's presidential election.
BPZ Resources (NYSE: BPZ) 8.8% LOWER; related to the election of Ollanta Humala.
Progress Software Corporation (NASDAQ: PRGS) 8.5% LOWER; reports preliminary results for Q2. Sees non-GAAP Q2 revs of $134 million and EPS of 37 to 38 cents. Consensus sees revs of $137.19 million and EPS of 42 cents.
FiberTower (Nasdaq: FTWR) 8.1% LOWER; continuing lower following a recent run-up. Shares fell more than 33 percent last week following a 98 percent surge over Thursday, May 26, the 27th and May 31st.
To get this movers report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James on Whirlpool Corporation (WHR): 'July Major Appliance Industrial Production Remained Weak'
- Capital One beats Q2 EPS by $1.13 as Discover integration gains pace
- After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Jim Cramer, Raymond James, Roth Capital, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
